Commission Implementing Regulation (EU) 2025/2034 updates the authorization details for the biocidal product “ClearKlens wipes based on IPA.” The key change involves administrative updates, specifically the name and address of the authorization holder, Diversey Europe Operations B.V., and the address of one of the product’s manufacturers. The regulation ensures that the product continues to meet safety standards.
Commission Implementing Regulation (EU) 2025/2027
Review of each of legal acts published today:
Commission Implementing Regulation (EU) 2025/2034 of 9 October 2025 amending Implementing Regulation (EU) 2024/2189 as regards administrative changes to the Union authorisation for the single biocidal product ClearKlens wipes based on IPA
This is a description of the Commission Implementing Regulation (EU) 2025/2034, which amends the Implementing Regulation (EU) 2024/2189 regarding the Union authorization for the single biocidal product “ClearKlens wipes based on IPA”. The new regulation updates the administrative information related to the authorization holder and manufacturer addresses for the specified biocidal product. It ensures that the changes are in line with the requirements of Regulation (EU) No 528/2012 and that the product’s characteristics remain compliant with the established standards.
The regulation consists of two articles and an annex. Article 1 replaces the annex to Implementing Regulation (EU) 2024/2189 with a new text that reflects the administrative changes. Article 2 states that the regulation will come into force twenty days after its publication in the Official Journal of the European Union. The annex provides a detailed summary of the biocidal product characteristics, including trade names, information about the authorization holder and manufacturers, the composition of the product, hazard and precautionary statements, authorized uses, and general directions for use. The main changes involve updating the name and address of the authorization holder (Diversey Europe Operations B.V.) and updating the address of one of the biocidal product manufacturers.
The most important provisions for users are those related to the authorized uses of the product, the specific instructions for use, risk mitigation measures, and safety information. The regulation specifies the application rates, frequency, and contact times for different uses, as well as the required personal protective equipment and ventilation conditions. It also provides instructions for the safe disposal of the product and its packaging, as well as the conditions of storage and shelf-life.
Commission Implementing Regulation (EU) 2025/2027 of 9 October 2025 amending Implementing Regulation (EU) No 540/2011 as regards the approval period of the active substance penthiopyrad
This Commission Implementing Regulation (EU) 2025/2027 concerns the active substance penthiopyrad, which is used in plant protection products. The regulation amends Implementing Regulation (EU) No 540/2011, specifically regarding the expiration date of the approval for penthiopyrad. Due to the applicant withdrawing their support for the renewal of approval, the previously extended approval period is shortened.
The regulation consists of two articles and an annex. Article 1 states that the Annex to Implementing Regulation (EU) No 540/2011 is amended as per the new regulation’s annex. Article 2 specifies that the regulation will come into force twenty days after its publication in the Official Journal of the European Union. The annex replaces the expiration date for penthiopyrad in Implementing Regulation (EU) No 540/2011 from 31 October 2027 to 31 October 2025. This cancels the extension granted by Implementing Regulation (EU) 2025/787.
The most important provision is the change to the expiration date of approval for penthiopyrad, setting it to 31 October 2025. This means that Member States must withdraw authorizations for plant protection products containing penthiopyrad by this date.
